Cipla News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

14.08.18	Ugandan drugmaker Cipla prices IPO at 256.5 shillings per share (Reuters)
14.08.18	Ugandan drugmaker Cipla prices IPO at 256.5 shillings per share (Reuters)
08.08.18	Cipla first-quarter profit trumps estimates on strong domestic growth (Reuters)
08.08.18	Cipla first-quarter profit trumps estimates (Reuters)
02.08.18	Uganda's Cipla Quality Chemical Industries says plans IPO, listing (Reuters)
02.08.18	Uganda's Cipla Quality Chemical Industries says plans IPO, listing (Reuters)
22.05.18	Cipla posts fourth quarter profit, misses estimates (Reuters)
07.02.18	Cipla third-quarter profit rises, but below estimates (Reuters)
07.11.17	Cipla second-quarter profit up 19 percent on higher domestic sales (Reuters)
07.11.17	Cipla second-quarter profit rises 19 percent (Reuters)
11.08.17	Cipla first-quarter profit rises 20 percent, beats estimates (Reuters)
25.05.17	Cipla lowers bio drugs investment, sharpens focus on respiratory (Reuters)
09.11.16	Cipla Q2 profit falls as Europe, emerging markets suffer (Reuters)
20.09.16	Drugmakers including Cipla, Wockhardt pledge to clean up antibiotic factories, curb overuse (Reuters)
12.08.16	Cipla first quarter profit lags estimates; names new CEO (Reuters)
24.05.16	Cipla Q4 profit lags due to one-off charges in Europe, emerging markets (Reuters)
05.11.15	Cipla Q2 net profit lags estimates (Reuters)
08.10.15	India's Cipla ties up with Serum Institute to sell vaccines in South Africa (Reuters)
08.10.15	Cipla ties up with Serum Institute to sell vaccines in South Africa (Reuters)
04.09.15	Cipla to buy Hetero Drugs' U.S. business for about $550 million - report (Reuters)
17.06.15	Cipla to sharpen focus on emerging markets in growth push (Reuters)
01.06.15	Lupin, Cipla bid for UCB's U.S. generic drugs portfolio - Bloomberg (Reuters)
10.03.15	Germany's Boehringer loses India patent on lung drug to Cipla (Reuters)
12.02.15	Cipla Q3 net profit up 15.5 pct (Reuters)
13.01.15	Delhi High Court bars Cipla from selling copy of Novartis respiratory drug (Reuters)
24.12.14	Aspen, Cipla win share of $860 mln S.Africa AIDS drug tender (Reuters)
24.12.14	Aspen, Cipla among winners in $860 mln S.Africa aids drug tender (Reuters)
24.12.14	Cipla among winners in $860 million S.Africa aids drug tender (Reuters)
17.12.14	Novartis sues Cipla over respiratory drug Onbrez (Reuters)
20.11.14	Cipla to market Serum Institute's paediatric vaccines in Europe (Reuters)
14.11.14	Cipla edges lower after sluggish exports hit earnings (Reuters)
30.10.14	Cipla asks government to revoke Novartis patents on respiratory drug (Reuters)
07.10.14	Drugmaker Cipla to set up manufacturing plant in Iran (Reuters)
18.09.14	Cipla grants Salix rights for Rifaximin (Reuters)
15.09.14	Gilead licenses hepatitis C drug to Cipla, Ranbaxy, five others (Reuters)
02.09.14	Cipla jumps 8.7 percent after key generic launch (Reuters)
01.09.14	Cipla launches copy of GSK's top asthma drug in Germany, Sweden (Reuters)
18.08.14	Cipla gains after April-June margins expand sequentially (Reuters)
14.08.14	Cipla Q1 net profit lags estimates as higher costs hurt (Reuters)
07.08.14	Cipla Medpro says awarded South Africa drug tender (Reuters)
26.06.14	South African govt awards $33 mln respiratory contract to Cipla (Reuters)
26.06.14	S.African govt awards $33 million respiratory contract to Cipla (Reuters)
29.05.14	Cipla Q4 net profit down 3 percent on higher costs (Reuters)
20.05.14	UBS downgrades Cipla to 'sell'; shares fall (Reuters)
13.02.14	Sensex falls; Cipla, Coal India down after earnings (Reuters)
13.02.14	Cipla falls after Dec-quarter earnings lag estimates (Reuters)
13.08.13	Morgan Stanley downgrades Cipla to "underweight" (Reuters)
12.08.13	Macquarie upgrades Cipla after Q1 earnings (Reuters)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Givaudan	4’040.00	1.71 %	K V
Geberit	547.80	1.59 %	K V
Part Grp Hldg	1’297.00	1.49 %	K V
ABB	51.94	1.29 %	K V
Swiss Life Hldg	691.80	1.26 %	K V
Zurich Insur Gr	548.00	-0.18 %	K V
Kuehne+Nagel Int	210.90	-0.33 %	K V
Swiss Re	128.20	-0.66 %	K V
Sonova Hldg	293.00	-0.85 %	K V
Novartis	87.94	-0.92 %	K V

Nachrichten zu Cipla Ltd.

Aktien Top/Flop

Meistgelesene Nachrichten